These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35081288)

  • 1. Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
    Rubin EJ; Baden LR; Barocas JA; Morrissey S
    N Engl J Med; 2022 Jan; 386(4):e16. PubMed ID: 35081288
    [No Abstract]   [Full Text] [Related]  

  • 2. Audio Interview: Covid-19 Vaccination and the Omicron Variant.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(27):e102. PubMed ID: 34965346
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(3):e18. PubMed ID: 34260844
    [No Abstract]   [Full Text] [Related]  

  • 4. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 5. Audio Interview: Waning Immunity against SARS-CoV-2.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(24):e99. PubMed ID: 34879456
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Oct; 385(15):e63. PubMed ID: 34614335
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omicron sparks a vaccine strategy debate.
    Cohen J
    Science; 2021 Dec; 374(6575):1544-1545. PubMed ID: 34941399
    [No Abstract]   [Full Text] [Related]  

  • 9. Audio Interview: Covid-19 and the Media.
    Rubin EJ; Baden LR; Tofel R; Morrissey S
    N Engl J Med; 2021 Sep; 385(14):e59. PubMed ID: 34587392
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccine breakthrough infections.
    Gupta RK; Topol EJ
    Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
    Al Jalali V; Scherzer S; Zeitlinger M
    Clin Microbiol Infect; 2021 Oct; 27(10):1529-1530. PubMed ID: 34192576
    [No Abstract]   [Full Text] [Related]  

  • 13. Audio Interview: Making Covid-19 Vaccines Available around the World.
    Rubin EJ; Baden LR; Hunter D; Morrissey S
    N Engl J Med; 2022 Mar; 386(10):e31. PubMed ID: 35263529
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    Hall VG; Ferreira VH; Ku T; Ierullo M; Majchrzak-Kita B; Chaparro C; Selzner N; Schiff J; McDonald M; Tomlinson G; Kulasingam V; Kumar D; Humar A
    N Engl J Med; 2021 Sep; 385(13):1244-1246. PubMed ID: 34379917
    [No Abstract]   [Full Text] [Related]  

  • 15. Audio Interview: The Omicron Variant of SARS-CoV-2.
    Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
    N Engl J Med; 2021 Dec; 385(23):e96. PubMed ID: 34874638
    [No Abstract]   [Full Text] [Related]  

  • 16. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audio Interview: Monoclonal Antibodies and Booster Shots.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Aug; 385(7):e29. PubMed ID: 34379932
    [No Abstract]   [Full Text] [Related]  

  • 18. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
    Regev-Yochay G; Gonen T; Gilboa M; Mandelboim M; Indenbaum V; Amit S; Meltzer L; Asraf K; Cohen C; Fluss R; Biber A; Nemet I; Kliker L; Joseph G; Doolman R; Mendelson E; Freedman LS; Harats D; Kreiss Y; Lustig Y
    N Engl J Med; 2022 Apr; 386(14):1377-1380. PubMed ID: 35297591
    [No Abstract]   [Full Text] [Related]  

  • 20. Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
    Qu P; Faraone JN; Evans JP; Zheng YM; Yu L; Ma Q; Carlin C; Lozanski G; Saif LJ; Oltz EM; Gumina RJ; Liu SL
    N Engl J Med; 2022 Oct; 387(14):1329-1331. PubMed ID: 36069925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.